Table 1

Demographic and clinical characteristics of study participants

Group; mean ± SD, or %ANOVAPost hoc group comparisons*
PHA (n = 33)DCG (n = 28)HCG (n = 31)
Age, yr40.1 ± 11.843.0 ± 12.342.3 ± 13.1F = 0.5
Female sex57.653.654.8χ2 = 0.1
Education ≥ 12 yr78.864.367.7χ2 = 1.8
Whiteley Index score10.6 ± 1.81.57 ± 1.350.87± 0.99F = 457.21 > 2,3
Short Health Anxiety Inventory score28.9 ± 4.68.4 ± 3.55.9 ± 2.8F = 363.11 > 2 > 3
Depressive symptoms score (PHQ-9)9.5 ± 4.517.0 ± 4.21.9 ± 2.4F = 117.12 > 1 > 3
Somatic symptoms score (PHQ-15)11.8 ± 4.38.4 ± 4.72.1 ± 1.7F = 54.01 > 2 > 3
Global Assessment of Functioning score6.83 ± 1.26.0 ± 0.99.4 ± 0.7F = 100.72 < 1 < 3
Current DSM-IV diagnosis
 Hypochondriasis63.600χ2 = 58.91 > 2,3
 Somatization disorder3.000χ2 = 1.7
 Major depression27.385.70χ2 = 53.92 > 1 > 3
 Dysthymia9.146.40χ2 = 23.02 > 1,3
 Generalized anxiety disorder12.100χ2 = 5.41 > 2,3
 Panic disorder33.300χ2 = 20.21 > 2,3
 Social phobia15.221.40χ2 = 7.91,2 > 3
 Specific phobia24.210.76.5χ2 = 4.1
 Obsessive–compulsive disorder9.100χ2 = 3.8
 Bulimia nervosa3.03.60χ2 = 1.3
  • ANOVA = analysis of variance; DCG = depression control group; HCG = healthy control group; PHA = pathological health anxiety group; PHQ = Patient Health Questionnaire; SD = standard deviation.

  • * Significant differences in post hoc group comparisons are indicated by the “>” symbol.